These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 229611)
1. Symposium on therapeutic controversies. Myasthenia gravis. Steroids and immunosuppressive drugs. Johns TR; Howard FM Trans Am Neurol Assoc; 1978; 103():278-81. PubMed ID: 229611 [No Abstract] [Full Text] [Related]
2. [Therapy of myasthenia gravis]. Jerusalem F Dtsch Med Wochenschr; 1977 Aug; 102(32):1160-3. PubMed ID: 196820 [No Abstract] [Full Text] [Related]
3. [Immuno suppressive drugs in the treatment of myasthenia (author's transl)]. Buscaino GA Riv Patol Nerv Ment; 1974 Aug; 95(4):399-410. PubMed ID: 4377801 [No Abstract] [Full Text] [Related]
4. [Preliminary observations of the treatment of myasthenia by azathioprine]. Delwaide PJ; Salmon J; Van Cauwenberge H Acta Neurol Psychiatr Belg; 1967 Sep; 67(9):701-12. PubMed ID: 4294559 [No Abstract] [Full Text] [Related]
5. Immunosuppressive therapy in neurological diseases. Cendrowski W; Riekkinen PJ; Rinne UK Ann Clin Res; 1974 Dec; 6(6):323-9. PubMed ID: 4375431 [No Abstract] [Full Text] [Related]
6. Plasmapheresis as a guide for azathioprine therapy in prednisone-resistant myasthenia gravis. Rodnitzky RL; Bosch EP Muscle Nerve; 1981; 4(6):529-30. PubMed ID: 7311992 [No Abstract] [Full Text] [Related]
7. [Treatment of myasthenia gravis]. Matell G; von Reis G Lakartidningen; 1973 Oct; 70(43):3821-5. PubMed ID: 4362569 [No Abstract] [Full Text] [Related]
11. Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis. Bromberg MB; Wald JJ; Forshew DA; Feldman EL; Albers JW J Neurol Sci; 1997 Sep; 150(1):59-62. PubMed ID: 9260858 [TBL] [Abstract][Full Text] [Related]
12. [Immunosuppressive treatment in neurological disorders]. Aarli JA Tidsskr Nor Laegeforen; 1973 Jun; 93(18):1395-7. PubMed ID: 4356438 [No Abstract] [Full Text] [Related]
13. [Amount of circulating acetylcholine receptor antibodies in the course of myasthenia, following thymectomy and in immunosuppressive therapy]. Patzold U; Kalies I; Haas J; Ginda EM Nervenarzt; 1984 Aug; 55(8):426-31. PubMed ID: 6483064 [No Abstract] [Full Text] [Related]
14. Effect of immunosuppressive drugs (azathioprine). Mertens HG; Hertel G; Reuther P; Ricker K Ann N Y Acad Sci; 1981; 377():691-9. PubMed ID: 6951493 [No Abstract] [Full Text] [Related]
15. Plasmapheresis: a new treatment modality for the patient with severe myasthenia gravis. Eppel M; Streib EW Nebr Med J; 1982 Apr; 67(4):72-4. PubMed ID: 7088214 [No Abstract] [Full Text] [Related]
16. The diagnosis and management of myasthenia gravis. Walsh JC Med J Aust; 1974 Jun; 1(25):997-1001. PubMed ID: 4369281 [No Abstract] [Full Text] [Related]
17. Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy. Brunner NG; Namba T; Grob D Neurology; 1972 Jun; 22(6):603-10. PubMed ID: 4343255 [No Abstract] [Full Text] [Related]
18. Antibodies against human cholinergic receptor proteins in patients with myasthenia gravis: Studies during immunosuppressive treatment. Preliminary report. Lefvert AK; Matell G Acta Med Scand; 1977; 201(3):181-2. PubMed ID: 192047 [No Abstract] [Full Text] [Related]
19. [Drug therapy in myasthenia gravis]. Aarli JA Tidsskr Nor Laegeforen; 1971 Apr; 91(10):726-8. PubMed ID: 4325239 [No Abstract] [Full Text] [Related]